2005
DOI: 10.2337/diabetes.54.12.3358
|View full text |Cite
|
Sign up to set email alerts
|

Peroxisome Proliferator–Activated Receptor (PPAR)α Activation Increases Adiponectin Receptors and Reduces Obesity-Related Inflammation in Adipose Tissue

Abstract: We examined the effects of activation of peroxisome proliferator-activated receptor (PPAR)␣, PPAR␥, and both of them in combination in obese diabetic KKAy mice and investigated the mechanisms by which they improve insulin sensitivity. PPAR␣ activation by its agonist, Wy-14,643, as

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
280
3
5

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 373 publications
(302 citation statements)
references
References 52 publications
14
280
3
5
Order By: Relevance
“…Similar to the current study Tsigos et al reported that plasma TNF␣ positively correlates with abdominal obesity [15]; however, there is no consensus about the contribution of fat depots to circulating levels of TNF␣ [14]. The increase in pro-inflammatory cytokines in adipose tissue is closely linked to the increase in adipose tissue resident macrophages [16]. The thiazolidinediones (TZDs) are known to have anti-inflammatory properties; one of the TZDs, rosiglitazone, has been shown to reduce the number of macrophages in white adipose tissue in mice [16], and hence to reduced macrophage-derived inflammatory cytokines.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…Similar to the current study Tsigos et al reported that plasma TNF␣ positively correlates with abdominal obesity [15]; however, there is no consensus about the contribution of fat depots to circulating levels of TNF␣ [14]. The increase in pro-inflammatory cytokines in adipose tissue is closely linked to the increase in adipose tissue resident macrophages [16]. The thiazolidinediones (TZDs) are known to have anti-inflammatory properties; one of the TZDs, rosiglitazone, has been shown to reduce the number of macrophages in white adipose tissue in mice [16], and hence to reduced macrophage-derived inflammatory cytokines.…”
Section: Discussionsupporting
confidence: 86%
“…The increase in pro-inflammatory cytokines in adipose tissue is closely linked to the increase in adipose tissue resident macrophages [16]. The thiazolidinediones (TZDs) are known to have anti-inflammatory properties; one of the TZDs, rosiglitazone, has been shown to reduce the number of macrophages in white adipose tissue in mice [16], and hence to reduced macrophage-derived inflammatory cytokines. TZDs also promote adipocyte differentiation and it is suggested that the smaller adipocytes which result from this are more insulin sensitive than large adipocytes [17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…22 We then developed an enzyme-linked immunosorbent assay for specific measurement of human HMW adiponectin. 23 The HMW adiponectin/total adiponectin ratio is more tightly correlated with insulin resistance than total adiponectin.…”
Section: High Molecular Weight (Hmw) Adiponectin As a Novel Biomarkermentioning
confidence: 99%
“…22 We next searched for strategies that could increase HMW adiponectin and found that a PPARg agonist and energy restriction upregulated the reduced HMW adiponectin. 22 Next, we attempted to clarify the relative contribution of adiponectin in the actions, such as antidiabetic effects, of a PPARg agonist. 25 In all, 10 mg kg À1 pioglitazone significantly ameliorated diabetes in ob/ob mice, but not in adiponectin deficient ob/ob mice.…”
Section: Development Of Novel Therapeutic Strategy Targeting Adiponectinmentioning
confidence: 99%